JP Morgan Chase
MXCT icon

JP Morgan Chase’s MaxCyte MXCT Stock Holding History

JP Morgan Chase’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.95K Sell
1,575
-39,517
-96% -$39.4K ﹤0.01% 7230
2026
Q1 		$27.8K Buy
41,092
+704
+2% +$657 ﹤0.01% 6427
2025
Q4 		$62.6K Sell
40,388
-24,388
-38% -$39K ﹤0.01% 6124
2025
Q3 		$102K Sell
64,776
-18,622
-22% -$32.4K ﹤0.01% 5887
2025
Q2 		$182K Sell
83,398
-8,926
-10% -$21.6K ﹤0.01% 5286
2025
Q1 		$252K Sell
92,324
-59,626
-39% -$235K ﹤0.01% 5142
2024
Q4 		$632K Sell
151,950
-42,049
-22% -$159K ﹤0.01% 4915
2024
Q3 		$755K Sell
193,999
-15,573
-7% -$65.6K ﹤0.01% 4643
2024
Q2 		$822K Sell
209,572
-32,000
-13% -$138K ﹤0.01% 4393
2024
Q1 		$1.01M Buy
241,572
+893
+0.4% +$4.19K ﹤0.01% 4337
2023
Q4 		$1.13M Sell
240,679
-117,148
-33% -$456K ﹤0.01% 4244
2023
Q3 		$1.12M Sell
357,827
-3,311
-0.9% -$13.3K ﹤0.01% 3985
2023
Q2 		$1.66M Sell
361,138
-18,717
-5% -$86K ﹤0.01% 3684
2023
Q1 		$1.88M Buy
379,855
+73,298
+24% +$361K ﹤0.01% 3587
2022
Q4 		$1.67M Buy
306,557
+37,797
+14% +$232K ﹤0.01% 3690
2022
Q3 		$1.75M Buy
268,760
+10,608
+4% +$59.2K ﹤0.01% 3583
2022
Q2 		$1.22M Buy
258,152
+149,266
+137% +$735K ﹤0.01% 3929
2022
Q1 		$762K Buy
108,886
+7,647
+8% +$52.2K ﹤0.01% 4443
2021
Q4 		$1.03M Buy
101,239
+81,613
+416% +$876K ﹤0.01% 4358
2021
Q3 		$239K Buy
+19,626
New +$296K ﹤0.01% 5142

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

JP Morgan Chase's MXCT Position: Q2 2026 in Review

JP Morgan Chase reduced its MaxCyte (MXCT) stake by 96% in Q2 2026, selling an estimated $39.4K and leaving 1,575 shares worth $1.95K. The position accounts for ﹤0.01% of the portfolio, ranked #7230.

JP Morgan Chase first reported a position in MXCT in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.88M in Q1 2023. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • JP Morgan Chase held 1,575 shares of MaxCyte worth $1.95K as of Q2 2026.
  • JP Morgan Chase sold 39,517 MaxCyte shares in Q2 2026, an estimated $39.4K.
  • MaxCyte made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7230 holding.
  • JP Morgan Chase first reported a position in MaxCyte in Q3 2021 and has held it in 20 quarters since.
  • JP Morgan Chase's MaxCyte position peaked at $1.88M in Q1 2023.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.